Squawk on the Street Cramer's Morning Take: Johnson & Johnson 4/1/25
Apr 1, 2025
Jim and Jeff dive into why Johnson & Johnson might be a wise investment despite its ongoing litigation risks surrounding talc products. They discuss the company's diverse drug portfolio and emerging market trends. The conversation also highlights the potential impact of a proposed 20% tariff on goods, emphasizing the importance of understanding international trade policies. They wrap up with insights on market sentiment and the importance of preparing for worst-case scenarios.
AI Snips
Chapters
Transcript
Episode notes
Worst-Case Scenario: Global Tariffs
- The worst-case scenario involves punitive tariffs globally, as reported by the Washington Post.
- If this scenario materializes, we might be through the worst of the situation.
Potential 20% Tariff
- The administration is considering a 20% tariff on goods, according to the Washington Post.
- This differs from reciprocal tariffs, as it's a blanket 20% tariff.
J&J Buy Opportunity
- Consider buying Johnson & Johnson (J&J) stock.
- It's an interesting opportunity because of a $7 billion exposure flowing back in.